Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-25-286218

Chief Executive Officer sold 10,916 shares at an average $25.20 ($275,047)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ceesay Abraham Chief Executive Officer 2025-11-17 Sale 10b5-1 −2,777 $24.92 $69,216 576,802 D: show line 1 in the form
Ceesay Abraham Chief Executive Officer 2025-11-17 Sale 10b5-1 −3,056 $25.43 $77,715 573,746 D: show line 2 in the form
Ceesay Abraham Chief Executive Officer 2025-11-17 Sale 10b5-1 −2,242 $24.91 $55,850 38,819 I: show line 3 in the form
Ceesay Abraham Chief Executive Officer 2025-11-17 Sale 10b5-1 −2,841 $25.44 $72,267 35,978 I: show line 4 in the form
Open-market sales · 10,916 sh · avg $25.20 · $275,047
Loading xslF345X05/ownership.xml…